Patents by Inventor Hermanus Henricus Gerardus Berendsen

Hermanus Henricus Gerardus Berendsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women
    Patent number: 7396854
    Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2C receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: July 8, 2008
    Assignee: N.V. Organon
    Inventor: Hermanus Henricus Gerardus Berendsen
  • Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women
    Patent number: 6987124
    Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2C receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: January 17, 2006
    Assignee: Akzo Nobel N.V.
    Inventor: Hermanus Henricus Gerardus Berendsen
  • Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women
    Publication number: 20030040519
    Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2C receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.
    Type: Application
    Filed: September 27, 2002
    Publication date: February 27, 2003
    Inventor: Hermanus Henricus Gerardus Berendsen
  • Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women
    Publication number: 20030032646
    Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2C receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxypyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.
    Type: Application
    Filed: September 27, 2002
    Publication date: February 13, 2003
    Inventor: Hermanus Henricus Gerardus Berendsen
  • Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
    Patent number: 6498184
    Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2c receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: December 24, 2002
    Assignee: Akzo Nobel N.V.
    Inventor: Hermanus Henricus Gerardus Berendsen
  • Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
    Publication number: 20020103206
    Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2c receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.
    Type: Application
    Filed: October 29, 2001
    Publication date: August 1, 2002
    Inventor: Hermanus Henricus Gerardus Berendsen
  • Therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
    Patent number: 6150353
    Abstract: This application relates to a combination of the antidepressant mirtazapine and an antipsychotic agent such as haloperidol for the treatment of psychotic disorders.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: November 21, 2000
    Assignee: Akzo Nobel N.V.
    Inventors: Christophorus Louis Eduard Broekkamp, Hermanus Henricus Gerardus Berendsen, Roger Martin Pinder